Unprecedented Growth, Questionable Policy: The 340B Drug Program

Congress established the 340B Drug Discount Program (340B) in 1992 to support access to prescription medicines for medically underserved populations. The program was designed to reduce outpatient drug costs for safety net providers and their patients by statutorily mandating
deep discounts from drug manufacturers as a condition of Medicaid reimbursement.